Novavax Inc vs Verizon Communications Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Verizon Communications Inc trades at $43.74 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 139.7× Novavax Inc's market cap, and Verizon Communications Inc pays a 6.51% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | VZ | |
|---|---|---|
Market Cap | $1.30B | $181.64B |
Sector | Health | Media |
52-Week High | $11.19 | $51.38 |
52-Week Low | $6.22 | $38.40 |
Enterprise Value | $800.50M | $369.14B |
Volume | — | 22,584,735 |
Dividend Yield | — | 6.51% |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →